NOW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ServiceNow is not a good immediate buy for a Beginner long-term investor with $50,000-$100,000 who is unwilling to wait for a better entry. The business quality and long-term AI growth story are strong, but the current price action is mixed, the stock is trading below recent resistance, options sentiment is bullish but extremely elevated in volatility, and congress trading is net negative. My direct view: hold off for now rather than buying today.
Price closed at 105.88, just under the 105.244-109.56 resistance zone and near short-term pivot levels. MACD is positive and expanding, which supports short-term upward momentum, but the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is still weak. RSI_6 at 67.19 is close to overbought but not extreme. The stock trend model suggests only modest near-term upside and a weaker month ahead, so the technical setup is not a clean long-term entry right now.
The company continues to benefit from AI product momentum and expanding workflow demand.
The broader price trend is still technically weak despite recent upbeat news. The stock is below several analyst targets and not showing a confirmed breakout. Hedge funds and insiders are neutral with no meaningful accumulation trend. Congress trading is net cautious: 3 sales versus 2 purchases, with larger sale amounts than buys. Also, the high implied volatility suggests the stock may already be pricing in a lot of good news.
Latest reported quarter: Q1 2026. ServiceNow posted strong growth, with subscription revenue up 22% year over year to $3.67B. That indicates healthy demand and continued expansion in its core software business, especially around AI features. Although full financial snapshot data was unavailable, the revenue growth trend remains strong and consistent with a high-quality long-term SaaS compounder.
Analyst sentiment is bullish overall. Recent actions include Guggenheim upgrading to Buy with a $125 target, Benchmark raising its target to $130 and maintaining Buy, BofA reinstating Buy at $130, Barclays at Overweight with $134, Citi at Buy with $154, and Bernstein at Outperform with a much higher $236 target. The pros view NOW as a profitable, durable AI beneficiary with strong workflow entrenchment. The main con is that some analysts still see deceleration risk and the stock already has a premium reputation, so upside may be more gradual than headline ratings suggest.
